Mental DisorderNCT03729050
Rehabilitation Coordinators in Specialist Psychiatry
A study testing Rehabilitation Coordinator in Specialist Psychiatry in people with Mental Disorder and Rehabilitation, run by Uppsala University at 1 site in Sweden.
Trial summary
REKO-A is a randomized controlled intervention study that addressed women and men on sick leave in Uppsala County. Participants which are on sick leave due to mental illness. Read more about this study
- Who is it for?
- Ages 25 to 64 years
- Conditions the study is for
- Mental Disorder, Rehabilitation
- What is being tested?
- Rehabilitation Coordinator in Specialist Psychiatry
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteSweden
- Study dates
- 24 Oct 2018to 31 Dec 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 64 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Be on sick leave
- Have moderate to severe affective and / or moderate / severe anxiety disorder, such as: Bipolar disorder, depression, posttraumatic stress disorder, generalized anxiety disorder, neuropsychiatric disability
- Enrolled at the Academic hospital in Uppsala
Who cannot join
- High suicidal risk
- Extensive somatic disorders (somatic multichannel)
- Patients outside Uppsala County
- Taking part in an ongoing vocational rehabilitation
Trial locations and contacts
1 site in 1 country.
Sweden1 site, 1 recruiting
- Recruiting
Uppsala university
Uppsala, SE-75122
Åsa Andersén, PHD, 00184716575, asa.andersen@pubcare.uu.se
Ingrid Anderzén, PHD
About this study
REKO-A is a randomized controlled intervention study that addressed women and men on sick leave in Uppsala County. Participants which are on sick leave due to mental illness.
- Conditions
- Mental Disorder, Rehabilitation
- Being tested
- Rehabilitation Coordinator in Specialist Psychiatry
- Keywords
- Mental Disorder, Rehabilitation
- Medical subject headings
- Mental Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Rehabilitation Coordinator in Specialist PsychiatryBehavioural
Rehabilitation Coordinator service in Specialist Psychiatry
| Study group | Role | What they receive |
|---|---|---|
| Intervention with rehabilitation coordinator | Experimental | Not described Receives: Behavioral: Rehabilitation Coordinator in Specialist Psychiatry |
| Control | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Return to work (RTW)/entry into work or studies
Number of Participants that have RTW/entry into work or studies
Measured: 1 year
Magnitude of sick leave
Proportion of sick leave in the study population
Measured: 1 year
Length of sick leave
Sick leave duration
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Nov 2018
- Study start24 Oct 2018
- Primary completion31 Dec 2020 (estimated)
- Study completion31 Dec 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Mental DisorderStudies of the same condition, open and under way.
- More trials run by Uppsala UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Uppsala University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ingrid Anderzen, Uppsala University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03729050
- Sponsor's protocol ID
- REKO-A
- Status last verified
- Jun 2020
- First submitted
- 31 Oct 2018
- Last updated
- 30 Jun 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Andersen A, Carpentsier B, Carlsson M, Berglund E, Anderzen I, Larsson K. Exploring healthcare professionals' views and experiences of having access to a rehabilitation coordinator in their work in psychiatric care: a qualitative descriptive study. BMC Health Serv Res. 2026 Oct 27;26(1):1478. doi: 10.1186/s12913-026-15919-8.
PubMed 42947172Andersen A, Berglund E, Anderzen I. Rehabilitation coordinator intervention versus control in psychiatric specialist care for return to work and reduced sick leave: study protocol of a randomised controlled trial. BMC Public Health. 2020 Feb 19;20(1):250. doi: 10.1186/s12889-020-8238-3.
PubMed 32075611
Study at a glance
From the registry record, last updated by the sponsor on 30 Jun 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Rehabilitation Coordinators in Specialist Psychiatry
- ClinicalTrials.gov ID
- NCT03729050
- Acronym / sponsor ID
- REKO-A
- Conditions
- Mental Disorder, Rehabilitation
- Keywords
- Mental Disorder, Rehabilitation
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Uppsala UniversityUniversity, hospital or other
- Study start
- 24 Oct 2018 (actual)
- Primary completion
- 31 Dec 2020 (estimated)
- Study completion
- 31 Dec 2021 (estimated)
- First posted
- 2 Nov 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
REKO-A is a randomized controlled intervention study that addressed women and men on sick leave in Uppsala County. Participants which are on sick leave due to mental illness.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention with rehabilitation coordinator | Experimental | Behavioral: Rehabilitation Coordinator in Specialist Psychiatry |
| Control | No intervention | – |
Who may qualify
- Ages
- 25 to 64 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Be on sick leave
- Have moderate to severe affective and / or moderate / severe anxiety disorder, such as: Bipolar disorder, depression, posttraumatic stress disorder, generalized anxiety disorder, neuropsychiatric disability
- Enrolled at the Academic hospital in Uppsala
Key exclusion criteria (4 listed)
- High suicidal risk
- Extensive somatic disorders (somatic multichannel)
- Patients outside Uppsala County
- Taking part in an ongoing vocational rehabilitation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Rehabilitation Coordinator in Specialist PsychiatryRehabilitation Coordinator service in Specialist Psychiatry | Behavioural | Intervention with rehabilitation coordinator |
Primary outcome
Return to work (RTW)/entry into work or studies
Time frame: 1 year
Number of Participants that have RTW/entry into work or studies
Magnitude of sick leave
Time frame: 1 year
Proportion of sick leave in the study population
Length of sick leave
Time frame: 1 year
Sick leave duration
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Jun 2020.
- Derived from this study: PubMed 42947172Andersen A, Carpentsier B, Carlsson M, Berglund E, Anderzen I, Larsson K. Exploring healthcare professionals' views and experiences of having access to a rehabilitation coordinator in their work in psychiatric care: a qualitative descriptive study. BMC Health Serv Res. 2026 Oct 27;26(1):1478. doi: 10.1186/s12913-026-15919-8.
- Derived from this study: PubMed 32075611Andersen A, Berglund E, Anderzen I. Rehabilitation coordinator intervention versus control in psychiatric specialist care for return to work and reduced sick leave: study protocol of a randomised controlled trial. BMC Public Health. 2020 Feb 19;20(1):250. doi: 10.1186/s12889-020-8238-3.
- Individual participant dataSharing planned: No
Related trials for Mental Disorder
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Enrolling by invitationPhase 3
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
ADHD
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Recruiting
Safety and Performance of UCon Patch Electrode
Urinary Incontinence, Urinary Incontinence, Urge
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Rehabilitation Coordinator in Specialist Psychiatry in people with Mental Disorder and Rehabilitation, run by Uppsala University at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 30 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Return to work (RTW)/entry into work or studies (time frame: 1 year). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03729050, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jun 2020.